Pizzie Nick, CFO of Axsome Therapeutics ($AXSM), made one open market sale of shares in the last year, totaling $2.3 million. The latest sale occurred on January 22, 2026. This ranks 3,257th among 11,678 insiders, below the average of $8.6 million across 6.4 transactions. No open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | Chief Financial Officer | A | Restricted Stock Units | 18570 | $0.00 | 18,570.0000 | 50,412,640 | 9999.99% | 0.04% |
| Jan. 22, 2026 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | Chief Financial Officer | M | Stock Option (Right to Buy) | 12000 | $0.00 | 105,000.0000 | 50,412,640 | 10.26% | 0.02% |
| Jan. 22, 2026 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | Chief Financial Officer | S | Common Stock | 12000 | $187.92 | 43,076.0000 | 50,412,640 | 21.79% | 0.02% |
| Jan. 22, 2026 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | Chief Financial Officer | M | Common Stock | 12000 | $3.50 | 55,076.0000 | 50,412,640 | 27.86% | 0.02% |
| Feb. 21, 2025 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 9516 | $0.00 | 9,516.0000 | 48,765,403 | 9999.99% | 0.02% |
| Feb. 21, 2025 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | Chief Financial Officer | A | Restricted Stock Units | 9423 | $0.00 | 9,423.0000 | 48,765,403 | 9999.99% | 0.02% |
| Feb. 24, 2025 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | Chief Financial Officer | A | Performance Stock Units | 9423 | $0.00 | 9,423.0000 | 48,765,403 | 9999.99% | 0.02% |
| Feb. 13, 2025 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | Chief Financial Officer | M | Stock Option (Right to Buy) | 12000 | $3.50 | 0.0000 | 48,765,403 | 100.00% | 0.02% |
| Feb. 14, 2025 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | Chief Financial Officer | M | Stock Option (Right to Buy) | 3000 | $3.50 | 0.0000 | 48,765,403 | 100.00% | 0.01% |
| Feb. 14, 2025 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | Chief Financial Officer | S | Common Stock | 3000 | $131.07 | 42,675.0000 | 48,765,403 | 6.57% | 0.01% |
| Feb. 14, 2025 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | Chief Financial Officer | M | Common Stock | 3000 | $3.50 | 45,675.0000 | 48,765,403 | 7.03% | 0.01% |
| Feb. 13, 2025 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | Chief Financial Officer | S | Common Stock | 12000 | $129.86 | 42,675.0000 | 48,765,403 | 21.95% | 0.02% |
| Feb. 13, 2025 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | Chief Financial Officer | M | Common Stock | 12000 | $3.50 | 54,675.0000 | 48,765,403 | 28.12% | 0.02% |
| Feb. 27, 2024 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | CHIEF FINANCIAL OFFICER | A | Employee Stock Option (Right to Buy) | 28722 | $0.00 | 28,722.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2024 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 15774 | $0.00 | 15,774.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | CHIEF FINANCIAL OFFICER | A | Employee Stock Option (Right to Buy) | 36246 | $0.00 | 36,246.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | Axsome Therapeutics, Inc. | $AXSM | Pizzie Nick | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 20554 | $0.00 | 20,554.0000 | 0 | 9999.99% | 0.00% |